Seletracetam
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Epilepsy | Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures | Phase 2 |
N01191
Completed |
NCT00152451 |
LINK
|
||
| Epilepsy | Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam | Phase 2 |
N01192
Completed |
NCT00152503 | |||
| Epilepsy | Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy | Phase 3 |
N01197
Terminated |
NCT00175851 | |||
| Epilepsy | A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures | Phase 2 |
N01272
Terminated |
NCT00422110 |